>
Big Tech Dominance Ties to Technocracy Agenda...
ITALIAN RESTAURANTS DEMAND "LIBERTÁ" FROM LOCKDOWNS
Peter Thiel bought an $18 million island estate in Miami that was once featured on MTV's...
The New Domestic War on Terror is Coming
Autonomous Flight unveils six-seat eVTOL tricopter air shuttle
Full Autonomous Self Driving Teslas in Vegas Boring Tunnels by the End of 2021
Fish-inspired robots coordinate movements without any outside control
The UK Is Developing Nuclear-Powered Space Exploration for Faster Mars Trips
GM Unveils Cadillac Flying Car For Rich People
Gigafactories With New Solar PV Module Tech Might Cause Solar Glut in 2021
Orbital Assembly Building Parts to Eventually Scale to Large Rotating Space Stations
GM Unveils Cadillac Flying Car For Rich People
How Phoenix Feeds The Hungry With Fresh Food While Saving Local Businesses and Farms
Oak Ridge Research Next Generation Cathode Free Lithium Ion Batteries
The research suggests this mechanism could be translatable to humans, offering new research pathways in the search for an anti-aging drug.
Mitochondria are tiny structures that act like cellular power plants. As we age mitochondria become increasingly dysfunctional and, in the search for lifespan-extending medicines, some scientists are looking at ways to repair these fundamental structures.
When mitochondria are damaged a process called mitochondrial unfolded protein response (UPRmt) is sometimes triggered. This mechanism involves the repair of mitochondria, and some anti-aging researchers suspect we could live longer if this process could be activated by taking a drug.
"Even though aging is not a disease, drugs may slow down aging and mitigate or prevent its negative effects on our health," says Eriko Kage-Nakadai, one of the scientists working on the new research.
Kage-Nakadai led a team of scientists from Osaka City University to set out to discover whether there are any pre-existing drugs that can trigger UPRmt. The first step involved screening around 3,000 known drugs in worms that had been genetically engineered to glow when a gene called hsp-6 is activated. This gene is known to be highly expressed during the process of UPRmt.
One drug called metolazone quickly stood out as significant in its effect on the hsp-6 gene. Metolazone is a common drug used to treat high blood pressure and it has been in clinical use for nearly 50 years.